<DOC>
	<DOC>NCT01051323</DOC>
	<brief_summary>This observational study will investigate hemoglobin levels and Mircera (methoxy polyethyleneglycol-epoetin beta) dose over time in patients with chronic kidney disease, and compare standards of care between centers. Data from each patient will be collected over 12 months of Mircera therapy.</brief_summary>
	<brief_title>An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>adult patients, &gt;/= 18 years of age chronic kidney disease informed consent for data transmission serious hematological or infectious disease acute bleeding in the 16 weeks preceding data collection participation in an interventional trial female patients: pregnancy or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>